Navigation Links
Spiral Flow[TM] Grafts Offer Superior Clinical Outcomes in Prosthetic Bypass Grafting
Date:11/20/2012

DUNDEE, Scotland, November 20, 2012 /PRNewswire/ --

Mr Shaper FRCS, Consultant Vascular Surgeon at Bradford Royal Infirmary, said, "The study showed significantly encouraging initial results for the use of Spiral Laminar Flow[TM] grafts in lower extremity bypasses to warrant continued usage and further long term data acquisition."

Initial results, from the on-going study, were presented at the 39th Annual Veith Symposium on Friday 16th November, 2012 in New York, USA. The study followed up the implantation of 31 Spiral Flow[TM] peripheral vascular grafts (Vascular Flow Technologies, Dundee, UK) between February 2011 to October 2012 with prospective data on-going and a retrospective analysis of 136 conventional ePTFE grafts  from same unit implanted between January 2003 to December 2008. The comparison presented was based on 1 year data available on 114 conventional PTFE grafts and 12 SLF[TM] grafts. The patients all had lower extremity bypasses.

     (Photo: http://photos.prnewswire.com/prnh/20121120/577588 )

The study showed that primary patency for the SLF[TM] graft was 92% compared to 48% for the conventional PTFE graft and secondary patency 100% for the SLF[TM] graft compared to 55% for the conventional PTFE graft. The amputation rate in the SLF[TM] graft group was 0% compared to 10% for the conventional graft group.

The innovative design of the Spiral Flow[TM] Graft is different from all other prosthetic vascular grafts. Near the distal end of the graft there is a 'Spiral Flow Inducer'- an ePTFE helical ridge on the graft lumen which remodels turbulent blood flow created by diseased vessels and conventional grafts into the body's own natural spiral flow pattern.

Neointimal hyperplasia (NIH) is the primary cause of failure in prosthetic grafts. It is caused, to a large degree, by turbulent blood flow - the Spiral Flow[TM] Graft re-instates natural blood flow thereby eliminating turbulence as a cause of NIH.

For more information:
Call: +44(0)1382-598-532 E-mail: news@vascular-flow.com Visit: http://www.vascular-flow.com

For more press information contact:
Bill Allan: +44(0)7920-143-030
Caroline Thoms: +44(0)1382-598-532



'/>"/>
SOURCE Vascular Flow Technologies
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
2. Two Top Notch Cadaver Workshops Offered by joimax® in April
3. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
4. Patient Advocate Foundation Announces New Co-Pay Relief (CPR) Offerings for Patients Facing Health Issues Due to Electrolyte Imbalance
5. QIAGEN and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals
6. Cochlear™ Americas Adds the Nucleus® Support App to its Mobile Service Offerings
7. Genesis Biopharma Announces Termination of Previously Announced Proposed Public Offering
8. Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering
9. Novogen Board Approves US$4 Million Investment In Marshall Edwards Rights Offering
10. Boston Scientific and Philips Healthcare Announce Collaboration to Enhance Imaging Equipment Offering
11. San Diego Based Neurosurgeon Offers Groundbreaking Treatment to Restore Function for People Suffering from Mobility Inhibiting Paralysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2017)... 19, 2017  Researchers from DRUGSCAN ® and ... host a live, complimentary webinar titled, "Untangling methods to ... the real world" on Wednesday June 28, 2017 from ... This webinar will feature interviews with recreational and dependent ... manipulation techniques abusers use to prepare opioid tablets for ...
(Date:6/14/2017)... HAMPTON, Va. , June 14, 2017  ivWatch ... safety and effectiveness of intravenous (IV) therapy, is pleased ... in the category of Nonsurgical Hospital Supplies and Equipment ... premier awards program for the medtech industry. The award ... at the Jacob K. Javits Center in ...
(Date:6/13/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... the U.S. Food and Drug Administration (FDA) has notified the ... to its Zhejiang, China manufacturing facility ... "The successful clearance of the Warning Letter related to our ... a measure of the progress we have made in our ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... ... Studies show evidence that carotenoids and antioxidants derived either from the diet or ... But how often do ophthalmologists and optometrists in Sweden recommend the use of nutritional ... early symptoms of AMD? A study published recently in Dove Medical Press ...
(Date:6/23/2017)... ... June 23, 2017 , ... ... Newburgh, New York, has recently begun offering three new minimally invasive procedures to ... cutting-edge procedures and reducing downtime, Dr. Rubinstein is excited to bring microneedling, microneedling ...
(Date:6/23/2017)... ... June 23, 2017 , ... Everybody has their own ... others prefer to read it, and some people don't like it at all. FindaTopDoc ... what they found: , Erotic literature can give readers a taste of their deepest, ...
(Date:6/23/2017)... ... 2017 , ... The Aesthetic Channel has recently highlighted Dr. Ben Talei’s unique ... a proprietary technique that he calls the AuraLyft Facelift. The AuraLyft does ... patients can expect to look refreshed, rejuvenated, and revitalized. , Dr. Talei’s unique ...
(Date:6/23/2017)... Atlanta, Georgia (PRWEB) , ... June 23, 2017 ... ... Triple Negative Breast Cancer Conference from Sept. 18 to 20. , The two-day ... cancer (TNBC) subtype with the goal of improving patients’ lives and eliminating racial ...
Breaking Medicine News(10 mins):